MedPath

湖北一半天制药有限公司

Ownership
-
Established
2007-02-07
Employees
-
Market Cap
-
Website
http://www.ybtyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

52

NMPA:52

Drug Approvals

Compound Amino Acid Injection(15-HBC-SF)

Product Name
复方氨基酸注射液(15-HBC-SF)
Approval Number
国药准字H20258084
Approval Date
May 28, 2025
NMPA

Compound Amino Acid Injection(20AA)

Product Name
复方氨基酸注射液(20AA)
Approval Number
国药准字H20193346
Approval Date
Sep 30, 2024
NMPA

Compound Amino Acid Injection(18AA-V-SF)

Product Name
复方氨基酸注射液(18AA-Ⅴ-SF)
Approval Number
国药准字H20046192
Approval Date
Aug 26, 2024
NMPA

Compound Amino Acid lnjection (14AA-SF)

Product Name
复方氨基酸注射液 (14 aa-sf)
Approval Number
国药准字H20023293
Approval Date
Aug 26, 2024
NMPA

Compound Amino Acid Injection(18AA-V-SF)

Product Name
复方氨基酸注射液(18AA-Ⅴ-SF)
Approval Number
国药准字H20184123
Approval Date
Aug 26, 2024
NMPA

Compound Amino Acid Injection(14AA-SF)

Product Name
复方氨基酸注射液(14AA-SF)
Approval Number
国药准字H20174069
Approval Date
Aug 26, 2024
NMPA

Compound Amino Acid Injection(18AA-V-SF)

Product Name
复方氨基酸注射液(18AA-Ⅴ-SF)
Approval Number
国药准字H20046194
Approval Date
Aug 26, 2024
NMPA

Compound Amino Acid Injection(14AA-SF)

Product Name
复方氨基酸注射液(14AA-SF)
Approval Number
国药准字H20247101
Approval Date
May 13, 2024
NMPA

Compound Amino Acid Injection (14AA-SF)

Product Name
复方氨基酸注射液(14AA-SF)
Approval Number
国药准字H20247093
Approval Date
May 7, 2024
NMPA

Gemcitabine Hydrochloride for Injection

Product Name
Approval Number
国药准字H20143001
Approval Date
Jan 3, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.